| Ms Elizabeth Cotter Ehrich, MSW | |
|
21 Tory Ln, Arlington, VT 05250-8978 | |
| (802) 282-3302 | |
| (802) 375-6110 |
| Full Name | Ms Elizabeth Cotter Ehrich |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 21 Tory Ln, Arlington, Vermont |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720009731 | NPI | - | NPPES |
| 185932000 | Other | VT | MAGELLAN |
| NE6362 | Other | VT | EMPIRE BLUE CROSS BLUE SH |
| 1006776 | Medicaid | VT | |
| 1035699 | Other | VT | CIGNA |
| 25303 | Other | VT | EMPLOYEE BENEFIT SERVICE |
| 29576 | Other | VT | BLUE CROSS BLUE SHIELD |
| 965188 | Other | VT | MVP |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | 0890000615 (Vermont) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Elizabeth Cotter Ehrich, MSW 21 Tory Ln, Arlington, VT 05250-8978 Ph: (802) 282-3302 | Ms Elizabeth Cotter Ehrich, MSW 21 Tory Ln, Arlington, VT 05250-8978 Ph: (802) 282-3302 |
News Archive
"Later this week, a group of 26 people will meet in Liberia to discuss how the world should tackle global development challenges over the next decade or two," Ben Leo, global policy director of the ONE Campaign, writes in a TrustLaw opinion piece.
CytoSorbents Corporation, a critical care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine adsorber to reduce deadly inflammation in critically-ill and cardiac surgery patients, announced today that it has submitted an Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) to conduct its proposed clinical trial using CytoSorb® intra-operatively in patients undergoing complex cardiac surgery requiring the use of a heart-lung machine.
Women who have difficulty getting pregnant often turn to in-vitro fertilization (IVF), but it doesn't always work. Now scientists are taking a new approach to improve the technique by studying the proteins that could help ready a uterus for an embryo to implant in its wall.
The European Society for Paediatric Gastroenterology, Hepatology and Nutrition has today issued new guidance to physicians on the diagnosis of celiac disease in children recommending the no-biopsy approach at diagnosis for the majority of children suspected of having the disease.
Though a variety of immunotherapy-based strategies are being used against cancer, they are often hindered by the inability of the immune response to enter the immunosuppressive tumor microenvironment and to effectively mount a response to cancer cells.
› Verified 4 days ago
Ms. Paula Miriam Shulman, LCSW LADC Counselor Medicare: Medicare Enrolled Practice Location: 2843 Vt Route 313 W, Arlington, VT 05250 Phone: 802-379-5117 Fax: 802-375-2906 |